{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:38:36Z","timestamp":1794620316588,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) is a fatal hyperinflammatory disorder distinct from self-limiting EBV-induced infectious mononucleosis (IM). However, the immunological mechanisms underlying the divergence between benign EBV infection and fulminant HLH\u2014particularly in the absence of inherited immunodeficiency\u2014remains unclear, and systematic comparisons of immune landscapes across EBV-associated disease spectra are lacking. In this study, by enrolling children with IM and healthy volunteers as controls, we utilize single-cell RNA sequencing to identify unique immunological characteristics of EBV-HLH. Our analysis indicates that patients with EBV-HLH exhibite widespread activation of NF-\u03baB signaling pathway. Furthermore, excessive cytokine secretion by T and NK cells is observed, along with a shift in monocyte differentiation towards an inflammatory phenotype, and the aggregation of IDO1\n                    <jats:sup>+<\/jats:sup>\n                    monocytes. Metabolic pathway analysis reveals that L-kynurenine, a downstream metabolite of IDO1, is specifically elevated in EBV-HLH and mediates the production of multiple pro-inflammatory cytokines. Collectively, our study maps the immune landscape in pediatric EBV-HLH at single-cell resolution, uncovering potential role of IDO1\n                    <jats:sup>+<\/jats:sup>\n                    monocytes and L-kynurenine as biomarkers.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-62090-5","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T21:22:58Z","timestamp":1753478578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Biomarkers of pediatric Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis through single-cell transcriptomics"],"prefix":"10.1038","volume":"16","author":[{"given":"Jie","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8271-9320","authenticated-orcid":false,"given":"Hong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keke","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biyun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1802-6415","authenticated-orcid":false,"given":"Zhi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0834-9306","authenticated-orcid":false,"given":"Wen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunchu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1903-6180","authenticated-orcid":false,"given":"Daolin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3746-1209","authenticated-orcid":false,"given":"Minghua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"62090_CR1","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","volume":"1","author":"MA Epstein","year":"1964","unstructured":"Epstein, M. A., Achong, B. G. & Barr, Y. M. Virus particles in cultured lymphoblasts from Burkitt\u2019s lymphoma. Lancet 1, 702\u2013703 (1964).","journal-title":"Lancet"},{"key":"62090_CR2","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1146\/annurev-immunol-032414-112326","volume":"33","author":"GS Taylor","year":"2015","unstructured":"Taylor, G. S., Long, H. M., Brooks, J. M., Rickinson, A. B. & Hislop, A. D. The immunology of Epstein-Barr virus-induced disease. Annu. Rev. Immunol. 33, 787\u2013821 (2015).","journal-title":"Annu. Rev. Immunol."},{"key":"62090_CR3","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1016\/j.cell.2022.08.026","volume":"185","author":"B Damania","year":"2022","unstructured":"Damania, B., Kenney, S. C. & Raab-Traub, N. Epstein-Barr virus: biology and clinical disease. Cell 185, 3652\u20133670 (2022).","journal-title":"Cell"},{"key":"62090_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/bjh.17638","volume":"196","author":"NK El-Mallawany","year":"2022","unstructured":"El-Mallawany, N. K., Curry, C. V. & Allen, C. E. Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes. Br. J. Haematol. 196, 31\u201344 (2022).","journal-title":"Br. J. Haematol."},{"key":"62090_CR5","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1182\/blood.2019000936","volume":"135","author":"SW Canna","year":"2020","unstructured":"Canna, S. W. & Marsh, R. A. Pediatric hemophagocytic lymphohistiocytosis. Blood 135, 1332\u20131343 (2020).","journal-title":"Blood"},{"key":"62090_CR6","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1111\/apa.15973","volume":"110","author":"S Imashuku","year":"2021","unstructured":"Imashuku, S., Morimoto, A. & Ishii, E. Virus-triggered secondary hemophagocytic lymphohistiocytosis. Acta Paediatr. 110, 2729\u20132736 (2021).","journal-title":"Acta Paediatr."},{"key":"62090_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/bjh.14147","volume":"174","author":"E Brisse","year":"2016","unstructured":"Brisse, E., Wouters, C. H. & Matthys, P. Advances in the pathogenesis of primary and secondary haemophagocytic lymphohistiocytosis: differences and similarities. Br. J. Haematol. 174, 203\u2013217 (2016).","journal-title":"Br. J. Haematol."},{"key":"62090_CR8","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s12026-022-09285-w","volume":"70","author":"H-Q Zhang","year":"2022","unstructured":"Zhang, H.-Q. et al. Cytokine storm and targeted therapy in hemophagocytic lymphohistiocytosis. Immunol. Res. 70, 566\u2013577 (2022).","journal-title":"Immunol. Res."},{"key":"62090_CR9","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00277-023-05132-6","volume":"102","author":"W Ou","year":"2023","unstructured":"Ou, W. et al. Serum cytokine pattern in children with hemophagocytic lymphohistiocytosis. Ann. Hematol. 102, 729\u2013739 (2023).","journal-title":"Ann. Hematol."},{"key":"62090_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/ejh.12399","volume":"94","author":"K-N Koh","year":"2015","unstructured":"Koh, K.-N. et al. Clinical features, genetics, and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in Korea: report of a nationwide survey from Korea Histiocytosis Working Party. Eur. J. Haematol. 94, 51\u201359 (2015).","journal-title":"Eur. J. Haematol."},{"key":"62090_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1532\/IJH97.07012","volume":"86","author":"E Ishii","year":"2007","unstructured":"Ishii, E. et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int. J. Hematol. 86, 58\u201365 (2007).","journal-title":"Int. J. Hematol."},{"key":"62090_CR12","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41392-023-01622-1","volume":"8","author":"M-Z Qiu","year":"2023","unstructured":"Qiu, M.-Z. et al. Dynamic single-cell mapping unveils Epstein\u2012Barr virus-imprinted T-cell exhaustion and on-treatment response. Signal Transduct. Target Ther. 8, 370 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"62090_CR13","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/s41422-020-00402-8","volume":"30","author":"S Jin","year":"2020","unstructured":"Jin, S. et al. Single-cell transcriptomic analysis defines the interplay between tumor cells, viral infection, and the microenvironment in nasopharyngeal carcinoma. Cell Res. 30, 950\u2013965 (2020).","journal-title":"Cell Res."},{"key":"62090_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1182\/blood.2023021074","volume":"143","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. Chronic active Epstein-Barr virus disease originates from infected hematopoietic stem cells. Blood 143, 32\u201341 (2024).","journal-title":"Blood"},{"key":"62090_CR15","volume":"10","author":"Y-Q Li","year":"2023","unstructured":"Li, Y.-Q. et al. Single-cell analysis reveals malignant cells reshape the cellular landscape and foster an immunosuppressive microenvironment of extranodal NK\/T-Cell lymphoma. Adv. Sci. (Weinh.) 10, e2303913 (2023).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"62090_CR16","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1182\/blood.V98.6.1882","volume":"98","author":"Y Kasahara","year":"2001","unstructured":"Kasahara, Y. et al. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood 98, 1882\u20131888 (2001).","journal-title":"Blood"},{"key":"62090_CR17","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1172\/JCI116721","volume":"92","author":"H Kawaguchi","year":"1993","unstructured":"Kawaguchi, H. et al. Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. J. Clin. Invest. 92, 1444\u20131450 (1993).","journal-title":"J. Clin. Invest."},{"key":"62090_CR18","first-page":"1219","volume":"144","author":"IJ Su","year":"1994","unstructured":"Su, I. J., Chen, R. L., Lin, D. T., Lin, K. S. & Chen, C. C. Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan. Am. J. Pathol. 144, 1219\u20131225 (1994).","journal-title":"Am. J. Pathol."},{"key":"62090_CR19","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1182\/blood.V96.2.443","volume":"96","author":"L Quintanilla-Martinez","year":"2000","unstructured":"Quintanilla-Martinez, L. et al. Fulminant EBV(+) T-cell lymphoproliferative disorder following acute\/chronic EBV infection: a distinct clinicopathologic syndrome. Blood 96, 443\u2013451 (2000).","journal-title":"Blood"},{"key":"62090_CR20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"J-I Henter","year":"2007","unstructured":"Henter, J.-I. et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr. Blood Cancer 48, 124\u2013131 (2007).","journal-title":"Pediatr. Blood Cancer"},{"key":"62090_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108255","volume":"101","author":"A Attiq","year":"2021","unstructured":"Attiq, A., Yao, L. J., Afzal, S. & Khan, M. A. The triumvirate of NF-\u03baB, inflammation and cytokine storm in COVID-19. Int. Immunopharmacol. 101, 108255 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"62090_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/imr.12791","volume":"291","author":"S Latour","year":"2019","unstructured":"Latour, S. & Fischer, A. Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: lessons from genetic diseases. Immunol. Rev. 291, 174\u2013189 (2019).","journal-title":"Immunol. Rev."},{"key":"62090_CR23","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1182\/blood.2019003886","volume":"135","author":"P Liu","year":"2020","unstructured":"Liu, P. et al. Nivolumab treatment of relapsed\/refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults. Blood 135, 826\u2013833 (2020).","journal-title":"Blood"},{"key":"62090_CR24","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/bjh.17058","volume":"191","author":"AC Chidambaram","year":"2020","unstructured":"Chidambaram, A. C., Maulik, K., Ramamoorthy, J. G. & Parameswaran, N. A novel mutation of adenosine deaminase causing SCID presenting as hemophagocytic lymphohistiocytosis with acute kidney injury. Br. J. Haematol. 191, 509\u2013512 (2020).","journal-title":"Br. J. Haematol."},{"key":"62090_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.immunol.16.1.89","volume":"16","author":"S Levy","year":"1998","unstructured":"Levy, S., Todd, S. C. & Maecker, H. T. CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu. Rev. Immunol. 16, 89\u2013109 (1998).","journal-title":"Annu. Rev. Immunol."},{"key":"62090_CR26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.kint.2021.02.025","volume":"100","author":"L Wu","year":"2021","unstructured":"Wu, L. et al. Annexin A1 alleviates kidney injury by promoting the resolution of inflammation in diabetic nephropathy. Kidney Int. 100, 107\u2013121 (2021).","journal-title":"Kidney Int."},{"key":"62090_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41423-023-01110-0","volume":"21","author":"Y Zheng","year":"2024","unstructured":"Zheng, Y. et al. Glioma-derived ANXA1 suppresses the immune response to TLR3 ligands by promoting an anti-inflammatory tumor microenvironment. Cell Mol. Immunol. 21, 47\u201359 (2024).","journal-title":"Cell Mol. Immunol."},{"key":"62090_CR28","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1161\/CIRCULATIONAHA.118.039345","volume":"140","author":"EY Senchenkova","year":"2019","unstructured":"Senchenkova, E. Y. et al. Novel role for the AnxA1-Fpr2\/ALX signaling axis as a key regulator of platelet function to promote resolution of inflammation. Circulation 140, 319\u2013335 (2019).","journal-title":"Circulation"},{"key":"62090_CR29","doi-asserted-by":"publisher","unstructured":"Tang, F. et al. A pan-cancer single-cell panorama of human natural killer cells. Cell 186, https:\/\/doi.org\/10.1016\/j.cell.2023.07.034 (2023).","DOI":"10.1016\/j.cell.2023.07.034"},{"key":"62090_CR30","doi-asserted-by":"publisher","first-page":"188","DOI":"10.15252\/emmm.201708292","volume":"10","author":"S Winter","year":"2018","unstructured":"Winter, S. et al. Loss of RASGRP1 in humans impairs T-cell expansion leading to Epstein-Barr virus susceptibility. EMBO Mol. Med. 10, 188\u2013199 (2018).","journal-title":"EMBO Mol. Med."},{"key":"62090_CR31","doi-asserted-by":"publisher","first-page":"6497","DOI":"10.1074\/jbc.271.11.6497","volume":"271","author":"Y Chu","year":"1996","unstructured":"Chu, Y., Solski, P. A., Khosravi-Far, R., Der, C. J. & Kelly, K. The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation. J. Biol. Chem. 271, 6497\u20136501 (1996).","journal-title":"J. Biol. Chem."},{"key":"62090_CR32","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1177\/154405910708600902","volume":"86","author":"JF Schindler","year":"2007","unstructured":"Schindler, J. F., Monahan, J. B. & Smith, W. G. p38 pathway kinases as anti-inflammatory drug targets. J. Dent. Res. 86, 800\u2013811 (2007).","journal-title":"J. Dent. Res."},{"key":"62090_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154545","volume":"108","author":"Z Li","year":"2023","unstructured":"Li, Z. et al. Xuanfei Baidu formula alleviates impaired mitochondrial dynamics and activated NLRP3 inflammasome by repressing NF-kappaB and MAPK pathways in LPS-induced ALI and inflammation models. Phytomedicine 108, 154545 (2023).","journal-title":"Phytomedicine"},{"key":"62090_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo, Q. et al. NF-kappaB in biology and targeted therapy: new insights and translational implications. Signal Transduct. Target Ther. 9, 53 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"62090_CR35","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1182\/blood-2005-04-1406","volume":"106","author":"HC Chuang","year":"2005","unstructured":"Chuang, H. C. et al. Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome. Blood 106, 3090\u20133096 (2005).","journal-title":"Blood"},{"key":"62090_CR36","doi-asserted-by":"publisher","first-page":"16085","DOI":"10.1074\/jbc.274.23.16085","volume":"274","author":"AG Eliopoulos","year":"1999","unstructured":"Eliopoulos, A. G., Gallagher, N. J., Blake, S. M., Dawson, C. W. & Young, L. S. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. J. Biol. Chem. 274, 16085\u201316096 (1999).","journal-title":"J. Biol. Chem."},{"key":"62090_CR37","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1600-065X.2009.00837.x","volume":"232","author":"Y Kulathu","year":"2009","unstructured":"Kulathu, Y., Grothe, G. & Reth, M. Autoinhibition and adapter function of Syk. Immunol. Rev. 232, 286\u2013299 (2009).","journal-title":"Immunol. Rev."},{"key":"62090_CR38","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu, X. et al. Reversed graph embedding resolves complex single-cell trajectories. Nat. Methods 14, 979\u2013982 (2017).","journal-title":"Nat. Methods"},{"key":"62090_CR39","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1084\/jem.189.9.1363","volume":"189","author":"DH Munn","year":"1999","unstructured":"Munn, D. H. et al. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189, 1363\u20131372 (1999).","journal-title":"J. Exp. Med."},{"key":"62090_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45954-0","volume":"15","author":"V Gerke","year":"2024","unstructured":"Gerke, V. et al. Annexins-a family of proteins with distinctive tastes for cell signaling and membrane dynamics. Nat. Commun. 15, 1574 (2024).","journal-title":"Nat. Commun."},{"key":"62090_CR41","doi-asserted-by":"publisher","unstructured":"Yang, Y. H. et al. Deficiency of annexin A1 in CD4+ T cells exacerbates T cell-dependent inflammation. J. Immunol. 190, https:\/\/doi.org\/10.4049\/jimmunol.1202236 (2013).","DOI":"10.4049\/jimmunol.1202236"},{"key":"62090_CR42","doi-asserted-by":"publisher","unstructured":"Yudhawati, R. & Shimizu, K. PGE2 produced by exogenous MSCs promotes immunoregulation in ARDS induced by highly pathogenic influenza A through activation of the Wnt-\u03b2-catenin signaling pathway. Int. J. Mol. Sci. 24, https:\/\/doi.org\/10.3390\/ijms24087299 (2023).","DOI":"10.3390\/ijms24087299"},{"key":"62090_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1114103","volume":"14","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. RIPK1 in the inflammatory response and sepsis: recent advances, drug discovery and beyond. Front. Immunol. 14, 1114103 (2023).","journal-title":"Front. Immunol."},{"key":"62090_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.886225","volume":"13","author":"LMF Merlo","year":"2022","unstructured":"Merlo, L. M. F., Peng, W. & Mandik-Nayak, L. Impact of IDO1 and IDO2 on the B cell immune response. Front. Immunol. 13, 886225 (2022).","journal-title":"Front. Immunol."},{"key":"62090_CR45","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","volume":"18","author":"M Platten","year":"2019","unstructured":"Platten, M., Nollen, E. A. A., R\u00f6hrig, U. F., Fallarino, F. & Opitz, C. A. Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat. Rev. Drug Discov. 18, 379\u2013401 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"62090_CR46","doi-asserted-by":"publisher","unstructured":"Fujii, K., Yamamoto, Y., Mizutani, Y., Saito, K. & Seishima, M. Indoleamine 2,3-dioxygenase 2 deficiency exacerbates imiquimod-induced psoriasis-like skin inflammation. Int. J. Mol. Sci. 21, https:\/\/doi.org\/10.3390\/ijms21155515 (2020).","DOI":"10.3390\/ijms21155515"},{"key":"62090_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102461","volume":"110","author":"Y Fujiwara","year":"2022","unstructured":"Fujiwara, Y. et al. Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy. Cancer Treat. Rev. 110, 102461 (2022).","journal-title":"Cancer Treat. Rev."},{"key":"62090_CR48","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13045-018-0644-y","volume":"11","author":"M Liu","year":"2018","unstructured":"Liu, M. et al. Targeting the IDO1 pathway in cancer: from bench to bedside. J. Hematol. Oncol. 11, 100 (2018).","journal-title":"J. Hematol. Oncol."},{"key":"62090_CR49","doi-asserted-by":"publisher","first-page":"5427","DOI":"10.1158\/1078-0432.CCR-15-0420","volume":"21","author":"L Zhai","year":"2015","unstructured":"Zhai, L. et al. Molecular pathways: targeting IDO1 and other tryptophan dioxygenases for cancer immunotherapy. Clin. Cancer Res. 21, 5427\u20135433 (2015).","journal-title":"Clin. Cancer Res."},{"key":"62090_CR50","doi-asserted-by":"publisher","unstructured":"Yero, A., Bouassa, R.-S. M., Ancuta, P., Estaquier, J. & Jenabian, M.-A. Immuno-metabolic control of the balance between Th17-polarized and regulatory T-cells during HIV infection. Cytokine Growth Factor Rev. 69, https:\/\/doi.org\/10.1016\/j.cytogfr.2023.01.001 (2023).","DOI":"10.1016\/j.cytogfr.2023.01.001"},{"key":"62090_CR51","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/cid\/ciab232","volume":"73","author":"C Adu-Gyamfi","year":"2021","unstructured":"Adu-Gyamfi, C. et al. Plasma Kynurenine-to-Tryptophan ratio, a highly sensitive blood-based diagnostic tool for tuberculosis in pregnant women living with human immunodeficiency virus (HIV). Clin. Infect. Dis. 73, 1027\u20131036 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"62090_CR52","doi-asserted-by":"publisher","first-page":"e66546","DOI":"10.1371\/journal.pone.0066546","volume":"8","author":"L Huang","year":"2013","unstructured":"Huang, L. et al. Induction and role of indoleamine 2,3 dioxygenase in mouse models of influenza a virus infection. PLoS ONE 8, e66546 (2013).","journal-title":"PLoS ONE"},{"key":"62090_CR53","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/hep.28282","volume":"63","author":"S Yoshio","year":"2016","unstructured":"Yoshio, S. et al. Indoleamine-2,3-dioxygenase as an effector and an indicator of protective immune responses in patients with acute hepatitis B. Hepatology 63, 83\u201394 (2016).","journal-title":"Hepatology"},{"key":"62090_CR54","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/jmv.25083","volume":"91","author":"R Yang","year":"2019","unstructured":"Yang, R., Gao, N., Chang, Q., Meng, X. & Wang, W. The role of IDO, IL-10, and TGF-\u03b2 in the HCV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. J. Med. Virol. 91, 265\u2013271 (2019).","journal-title":"J. Med. Virol."},{"key":"62090_CR55","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.micinf.2004.04.007","volume":"6","author":"O Adams","year":"2004","unstructured":"Adams, O. et al. Inhibition of human herpes simplex virus type 2 by interferon gamma and tumor necrosis factor alpha is mediated by indoleamine 2,3-dioxygenase. Microbes Infect. 6, 806\u2013812 (2004).","journal-title":"Microbes Infect."},{"key":"62090_CR56","doi-asserted-by":"publisher","unstructured":"M\u00fcller-Durovic, B. et al. A metabolic dependency of EBV can be targeted to hinder B cell transformation. Science, eadk4898, https:\/\/doi.org\/10.1126\/science.adk4898 (2024).","DOI":"10.1126\/science.adk4898"},{"key":"62090_CR57","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41586-024-07962-4","volume":"634","author":"B Feng","year":"2024","unstructured":"Feng, B. et al. The type 2 cytokine Fc-IL-4 revitalizes exhausted CD8+ T cells against cancer. Nature 634, 712\u2013720 (2024).","journal-title":"Nature"},{"key":"62090_CR58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"62090_CR59","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"62090_CR60","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation (Camb.) 2, 100141 (2021).","journal-title":"Innovation (Camb.)"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62090-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62090-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62090-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:01:34Z","timestamp":1757307694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62090-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["62090"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-62090-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"21 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6888"}}